[go: up one dir, main page]

NO983283L - Hydrocamic acid-based collagenase inhibitors - Google Patents

Hydrocamic acid-based collagenase inhibitors

Info

Publication number
NO983283L
NO983283L NO983283A NO983283A NO983283L NO 983283 L NO983283 L NO 983283L NO 983283 A NO983283 A NO 983283A NO 983283 A NO983283 A NO 983283A NO 983283 L NO983283 L NO 983283L
Authority
NO
Norway
Prior art keywords
hydrocamic
acid
collagenase inhibitors
alkenyl
aryl
Prior art date
Application number
NO983283A
Other languages
Norwegian (no)
Other versions
NO983283D0 (en
Inventor
Stuart Bailey
Derek Richard Buckle
Andrew Faller
David Glynn Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO983283D0 publication Critical patent/NO983283D0/en
Publication of NO983283L publication Critical patent/NO983283L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelser med formel (I): HON NHRJ ROR' (I) hvor R og R3 er hver uavhengig hydrogen, alkyl, alkenyl, alkynyl eller aryl; R1 er arylmetyl; og R2 er alkyl. alkenyl, aryl, cykloalkyl eller cykloalkenyl og farmasøytisk akseptable derivater derav, er nyttige ved behandling og profylakse av tilstander hvor overproduksjon av sCD23 inngår.Compounds of formula (I): HON NHRJ ROR '(I) wherein R and R3 are each independently hydrogen, alkyl, alkenyl, alkynyl or aryl; R 1 is arylmethyl; and R 2 is alkyl. alkenyl, aryl, cycloalkyl or cycloalkenyl and pharmaceutically acceptable derivatives thereof, are useful in the treatment and prophylaxis of conditions involving the overproduction of sCD23.

NO983283A 1996-01-17 1998-07-16 Hydrocamic acid-based collagenase inhibitors NO983283L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9601041.8A GB9601041D0 (en) 1996-01-17 1996-01-17 Novel compounds
PCT/EP1997/000196 WO1997026257A1 (en) 1996-01-17 1997-01-14 Hydroxamic acid based collagenase inhibitors

Publications (2)

Publication Number Publication Date
NO983283D0 NO983283D0 (en) 1998-07-16
NO983283L true NO983283L (en) 1998-09-16

Family

ID=10787226

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983283A NO983283L (en) 1996-01-17 1998-07-16 Hydrocamic acid-based collagenase inhibitors

Country Status (19)

Country Link
EP (1) EP0912545A1 (en)
JP (1) JP2000503312A (en)
KR (1) KR19990077325A (en)
CN (1) CN1213368A (en)
AR (1) AR005472A1 (en)
AU (1) AU725056B2 (en)
BR (1) BR9707024A (en)
CA (1) CA2242913A1 (en)
CZ (1) CZ222498A3 (en)
GB (1) GB9601041D0 (en)
HU (1) HUP9901022A3 (en)
IL (1) IL125381A0 (en)
NO (1) NO983283L (en)
NZ (1) NZ326352A (en)
PL (1) PL327820A1 (en)
TR (1) TR199801380T2 (en)
TW (1) TW462967B (en)
WO (1) WO1997026257A1 (en)
ZA (1) ZA97345B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9609795D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
AU1960100A (en) * 1999-01-06 2000-07-24 Mcmaster University Method of preventing immune and hypersensitivity reactions
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
WO2002006227A1 (en) * 2000-07-18 2002-01-24 Chugai Seiyaku Kabushiki Kaisha Matrix metalloprotease inhibitors
MXPA04007311A (en) * 2002-01-28 2005-05-16 Aimsco Ltd Treatment of ms with goat serum.
US7521563B2 (en) 2004-08-10 2009-04-21 Shizuoka Coffein Co., Ltd. Hydroxamic acid derivative and medicine containing the same as active ingredient
KR100844277B1 (en) * 2005-04-29 2008-07-07 (주)아모레퍼시픽 A hydroxamic acid derivative and the preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
GB9504084D0 (en) * 1995-03-01 1995-04-19 British Biotech Pharm Synthesis of carboxylic and hydroxamic acid derivatives

Also Published As

Publication number Publication date
CN1213368A (en) 1999-04-07
AU725056B2 (en) 2000-10-05
NZ326352A (en) 2000-03-27
AR005472A1 (en) 1999-06-23
CA2242913A1 (en) 1997-07-24
HUP9901022A3 (en) 2001-11-28
KR19990077325A (en) 1999-10-25
JP2000503312A (en) 2000-03-21
HUP9901022A2 (en) 1999-07-28
NO983283D0 (en) 1998-07-16
AU1443697A (en) 1997-08-11
GB9601041D0 (en) 1996-03-20
ZA97345B (en) 1998-07-16
BR9707024A (en) 1999-07-20
PL327820A1 (en) 1999-01-04
WO1997026257A1 (en) 1997-07-24
CZ222498A3 (en) 1999-03-17
TR199801380T2 (en) 1998-10-21
TW462967B (en) 2001-11-11
EP0912545A1 (en) 1999-05-06
IL125381A0 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
NO954427L (en) HIV protease inhibitors useful for the treatment of AIDS
MY108885A (en) Heterocyclic-cyclic amine derivatives.
ATE215073T1 (en) TRI-SUBSTITUTED PHENYL DERIVATIVES USABLE AS PDE IV INHIBITORS
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
AU2001272666A1 (en) 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
FI931765A0 (en) STEROIDDERIVAT FOER BEHANDLING AV PROSTATAHYPERTROFI, DERAS FRAMSTAELLNING OCH ANVAENDNINGAR
FI935777A0 (en) Inhibitor Foer HIV-Proteas can be used to treat AIDS
ATE319680T1 (en) SUBSTITUTED 2-BENZYLAMINO-2-PHENYL-ACETAMIDE COMPOUNDS
NO983283L (en) Hydrocamic acid-based collagenase inhibitors
DE69808099D1 (en) SUBSTITUTED 6-ALKYLPHENANTHRIDINE
CA2139731A1 (en) 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
DE69625505D1 (en) GUANIDINO PROTEIASE INHIBITORS
NO900697L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ACETAMIDE DERIVATIVES.
DK0915841T3 (en) Anilinopeptide derivatives
UA26459C2 (en) INHIBITOR OF INFLUENCE OF AMYLOID PROTEINS
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
TR200003877T2 (en) Hiydroxamic acid derivatives, which are inhibitors of human CD23 production and TNF release
NO964522D0 (en) Process for Preparation of 5,6-Dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
NO993079L (en) Use of aminothiazoles as microbicides
DE69029069D1 (en) Use of xanthine derivatives against stomach ulcers
MX9804255A (en) Dithiazoldioxides and the use thereof as microbicides.
HUP0204144A2 (en) N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
ATE188468T1 (en) ANTIHERPETIC PEPTIDOMIMMETIC COMPOUNDS
NO912420L (en) ANTIATHEROSCLEROTIC AND ANTITROMOBOTIC 1-BENZOPYRANE-4-ONER AND 2-AMINO-1,3-BENZOKSAZIN-4-ONER.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application